The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ACLARIS THERAPEUTICS INC COM 00461U105   2,298,267 434,455 SH   SOLE   434,455 0 0
BICARA THERAPEUTICS INC COM 055477103   16,891,205 568,919 SH   SOLE   568,919 0 0
BIOMEA FUSION INC COM 09077A106   3,011,673 2,048,757 SH   SOLE   2,048,757 0 0
BRIDGEBIO ONCOLOGY THERAPEUT COM NEW 107924102   7,757,297 1,018,018 SH   SOLE   1,018,018 0 0
BRIDGEBIO PHARMA INC COM 10806X102   341,834,227 4,589,611 SH   SOLE   4,589,611 0 0
COMPASS PATHWAYS PLC SPONSORED ADS 20451W101   20,267,554 1,432,336 SH   SOLE   1,432,336 0 0
EUPRAXIA PHARMACEUTICALS INC COM 29842P105   2,148,250 325,000 SH   SOLE   325,000 0 0
MARKER THERAPEUTICS INC COM NEW 57055L206   478,293 325,370 SH   SOLE   325,370 0 0
MONTE ROSA THERAPEUTICS INC COM 61225M102   37,647,069 1,555,664 SH   SOLE   1,555,664 0 0
ONKURE THERAPEUTICS INC COM CL A 68277Q105   404,048 88,607 SH   SOLE   88,607 0 0
SCHOLAR ROCK HLDG CORP COM 80706P103   4,236,705 77,031 SH   SOLE   77,031 0 0
SYNDAX PHARMACEUTICALS INC COM 87164F105   28,785,379 1,316,806 SH   SOLE   1,316,806 0 0
UROGEN PHARMA LTD COM M96088105   3,974,400 108,000 SH   SOLE   108,000 0 0
VTV THERAPEUTICS INC CL A NEW 918385204   1,882,500 50,000 SH   SOLE   50,000 0 0